Fund Holdings — Sanofi

Total Portfolio Value:
$260.36M
Total Bought:
$18.96M
Total Sold:
$3.38M
Net Transaction:
+$15.58M
Securities
▲▼
SharesValue
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
MeiraGTx Holdings plc(MGTX)12,197,73712,197,7370$79.53M$100.39M38.56%+$20.86M
Novavax, Inc.(NVAX)6,880,4816,880,4810$43.35M$59.65M22.91%+$16.31M
Inhibrx Biosciences, Inc.(INBX)1,157,9261,157,9260$16.52M$39.00M14.98%+$22.48M
AnaptysBio821,917821,9170$18.25M$25.17M9.67%+$6.92M
Immuneering CorpCL A02,708,559+2,708,559$0$18.96M7.28%+$18.96M
Omada Health, Inc.(OMDA)524,903524,9030$9.61M$11.61M4.46%+$2.00M
LAVA Therapeutics N.V.SHS1,919,4551,919,4550$2.53M$2.99M1.15%+$460.7K
Eledon Pharmaceuticals, Inc.(ELDN)814,980814,9800$2.21M$2.11M0.81%-$97.8K
Q32 Bio Inc.(QTTB)244,083244,0830$363.7K$483.3K0.19%+$119.6K
IGM Biosciences1,438,9750-1,438,975$1.61M$0—-$1.61M
Inozyme, Inc443,2550-443,255$1.77M$0—-$1.77M
Page 1 of 1
Sanofi — 13F Holdings — Q3 2025 | TickerTrail